First-In-Human and Proof-of-Concept Trials
ver the past decades, Altasciences has designed and conducted over 200 first-in-human and stand-alone proof-of-concept studies. Our comprehensive, full service, early development offerings and experience help you develop sound strategies and allow you to minimize the time taken to make critical go/no-go decisions by harmonizing our clinical pharmacology facilities, biomarker capabilities, PK/PD analysis expertise, and program knowledge.
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.